Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 19/20 | 0.79 |
| ▸ | LY96 | Q9Y6Y9 | 5/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13641429 | 1.00 | TLR4 (0.79) | TLR4LY96 | |
| SCHEMBL13641425 | 1.00 | TLR4 (0.79) | TLR4LY96 | |
| SCHEMBL12061357 | 1.00 | TLR4 (0.79) | TLR4LY96 | |
| SCHEMBL13641408 | 1.00 | TLR4 (0.79) | TLR4LY96 | |
| SCHEMBL12061350 | 1.00 | TLR4 (0.79) | TLR4LY96 | |
| SCHEMBL16254599 | 0.98 | TLR4 (0.80) | TLR4LY96 | |
| SCHEMBL13480154 | 0.98 | TLR4 (0.80) | TLR4LY96 | |
| SCHEMBL12006180 | 0.98 | TLR4 (0.80) | TLR4LY96 | |
| SCHEMBL12075593 | 0.98 | TLR4 (0.80) | TLR4LY96 | |
| SCHEMBL16298813 | 0.98 | TLR4 (0.80) | TLR4LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150064240-A1 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant | ONCOTHYREON INC. | 2015-03-05 | — | — | US | disclosed |
| US-8889616-B2 | MUC1 based glycolipopeptide vaccine with adjuvant | ONCOTHYREON INC. (US) | 2014-11-18 | — | — | US | disclosed |
| US-20120219617-A1 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant | ONCOTHYREON INC. (US) | 2012-08-30 | — | — | US | disclosed |
| US-8097593-B1 | Lipid A and other carbohydrate ligand analogs | ONCOTHYREON INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20120003295-A1 | LIPID A AND OTHER CARBOHYDRATE LIGAND ANALOGS | ONCOTHYREON INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-7820627-B2 | Lipid A and other carbohydrate ligand analogs | ONCOTHYREON INC. (US) | 2010-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120003295-A1 | LIPID A AND OTHER CARBOHYDRATE LIGAND ANALOGS | SELPLG, STT3A, LY96 | TLR4 11/4885LY96 3/4885 |
| US-20150064240-A1 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant | MUC1, LGALS3BP, ST3GAL3 | TLR4 488/4885LY96 23/4885 |
| US-20120219617-A1 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant | MUC1, LGALS3BP, ST3GAL3 | TLR4 488/4885LY96 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.